Published in Women's Health Weekly, June 24th, 2004
Currently, the standard after-surgery treatment for post-menopausal women with primary breast cancer is a 5-year regimen of tamoxifen.
Led by Manish Gupta, Gerardo Trillo, and Charles S. White, Texas Oncology was one of 11 affiliates of U.S. Oncology that participated in the clinical trial.
"This is an important finding that could change the way that...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly